Latest news
Nearly 12 million eye drop bottles pulled nationwide after company says 'sterility cannot be assured' - The Cool DownThe Cool Down · Sat, 08 Aug 2026 01:38:00 GMTRohto Pharmaceutical (TSE:4527) Stock Grapples With Revenue Growth And Thinner Margins - simplywall.stsimplywall.st · Fri, 07 Aug 2026 13:54:10 GMTWellnex Life offloads Pain Away brand to Japan's Rohto Pharmaceutical subsidiary for up to $21.3m - Business News AustraliaBusiness News Australia · Thu, 06 Aug 2026 22:00:07 GMTRohto Pharmaceutical: Double-digit sales and profit growth in Q1 2026, with upwardly revised full-year forecasts - TradingViewTradingView · Thu, 06 Aug 2026 06:36:00 GMTRohto takes control of Okinawa marine biotech OPBio - Dealroom.coDealroom.co · Thu, 06 Aug 2026 02:16:07 GMTRohto Pharmaceutical Co. Revenue Breakdown – OTC:RPHCF - TradingViewTradingView · Wed, 05 Aug 2026 02:51:57 GMTNearly 12 million Rohto eye drops recalled in the US over sterility concerns - YahooYahoo · Tue, 04 Aug 2026 13:07:00 GMTRohto Cooling Eye Drops Pulled From Sale Nationwide Over Sterility Failure - South Philly ReviewSouth Philly Review · Mon, 03 Aug 2026 16:56:04 GMT